Skip to content

300451.SZ

创业慧康

SZSE · Healthcare · I 信息技术 · CN

CNY 3.40
−1.45%
Ask drillr

Year over year

Reported trailing growth

Revenue
-28.3%
EBITDA
EBIT
EPS
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
-74.1%
EBITDA
EPS

Three-year CAGR

Revenue
-11.7%
EBITDA
EBIT
Net income
EPS
Free cash flow
-51.2%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026